US Patent 11434265 Chimeric neurotoxins

Is a

Patent

Patent attributes

Patent Applicant

Ipsen

Current Assignee

Ipsen

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

11434265

Patent Inventor Names

Sai Man Liu0

Date of Patent

September 6, 2022

Patent Application Number

16094254

Date Filed

May 5, 2017

Patent Citations

‌

US Patent 10451621 Highly sensitive cell-based assay to detect the presence of active botulinum neurotoxin serotype-A

‌

US Patent 10457927 Multiprotease therapeutics for chronic pain

‌

US Patent 10501731 Degradable clostridial toxins

‌

US Patent 10647750 Cationic neurotoxins

‌

US Patent 10704035 Compositions and methods for treatment of pain

‌

US Patent 10709772 Use of botulinum neurotoxin in the treatment of sialorrhea

‌

US Patent 10786438 Recombinant nucleic acids encoding cosmetic protein(s) for aesthetic applications

‌

US Patent 10808236 Methods for the manufacture of proteolytically processed polypeptides

...

Patent Primary Examiner

‌

Nita M. Minnifield

The present invention relates to chimeric neurotoxins with enhanced properties and their use in therapy.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

US Patent 11434265 Chimeric neurotoxins

Contents

Patent attributes

Timeline

Further Resources

References

Find more entities like US Patent 11434265 Chimeric neurotoxins